IP Library Granted Patent US 12,059,552
Granted Patent B2
US 12,059,552 · App. 17/391,986 · Granted Aug 13, 2024

Configurable target glucose values

Inventors: Louis J. Lintereur (Boise, ID); Benyamin Grosman (Winnetka, CA); Anirban Roy (Agoura Hills, CA); Neha J. Parikh (West Hills, CA); Di Wu (Glendale, CA)
Assignee: MEDTRONIC MINIMED, INC.
A61M5/1723A61M5/145G16H20/17A61M2205/3569A61M2205/3584A61M2205/502A61M2205/52A61M2230/201
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,059,552
App. No.
17/391,986
Granted
Aug 13, 2024
Kind
B2
Abstract

A system includes one or more processors and one or more processor-readable storage media storing instructions which, when executed by the one or more processors, cause performance of obtaining a first target value for a glucose level of a patient, modifying a glucose setpoint from a second target value to the first target value, and regulating the glucose level of the patient to the modified glucose setpoint based on controlling insulin delivery by an insulin infusion device.

Claims (31)

1. A system comprising:

one or more processors; and

one or more processor-readable storage media storing instructions which, when executed by the one or more processors, cause performance of:

obtaining a first target value for a glucose level of a patient;

modifying a glucose setpoint from a second target value to the first target value, wherein the first target value is a clinically preferred target value; and

regulating the glucose level of the patient to the modified glucose setpoint based on controlling insulin delivery by an insulin infusion device.

2. The system of claim 1 , wherein obtaining the first target value comprises receiving, via a user interface, user input indicative of the first target value.

3. The system of claim 1 , wherein the first target value is a target value of a plurality of target values, each target value of the plurality of target values corresponding to a different time period of a glucose setpoint profile.

4. The system of claim 3 , wherein the glucose setpoint profile is automatically calculated based on historical data associated with operation of the insulin infusion device.

5. The system of claim 3 , wherein the glucose setpoint profile is obtained from a remote system or device.

6. The system of claim 1 , wherein the clinically preferred target value is automatically determined based on historical data associated with operation of the insulin infusion device.

7. The system of claim 6 , wherein the clinically preferred target value is obtained from a remote system or device.

8. A processor-implemented method comprising:

obtaining a first target value for a glucose level of a patient;

modifying a glucose setpoint from a second target value to the first target value, wherein the first target value is a clinically preferred target value; and

regulating the glucose level of the patient to the modified glucose setpoint based on controlling insulin delivery by an insulin infusion device.

9. The method of claim 8 , wherein obtaining the first target value comprises receiving, via a user interface, user input indicative of the first target value.

10. The method of claim 8 , wherein the first target value is a target value of a plurality of target values, each target value of the plurality of target values corresponding to a different time period of a glucose setpoint profile.

11. The method of claim 10 , wherein the glucose setpoint profile is automatically calculated based on historical data associated with operation of the insulin infusion device.

12. The method of claim 10 , wherein the glucose setpoint profile is obtained from a remote system or device.

13. The method of claim 8 , wherein the clinically preferred target value is automatically determined based on historical data associated with operation of the insulin infusion device.

14. The method of claim 13 , wherein the clinically preferred target value is obtained from a remote system or device.

15. One or more non-transitory processor-readable storage media storing instructions which, when executed by one or more processors, cause performance of:

obtaining a first target value for a glucose level of a patient;

modifying a glucose setpoint from a second target value to the first target value, wherein the first target value is a clinically preferred target value; and

regulating the glucose level of the patient to the modified glucose setpoint based on controlling insulin delivery by an insulin infusion device.

16. The one or more non-transitory processor-readable storage media of claim 15 , wherein obtaining the first target value comprises receiving, via a user interface, user input indicative of the first target value.

17. The one or more non-transitory processor-readable storage media of claim 15 , wherein the first target value is a target value of a plurality of target values, each target value of the plurality of target values corresponding to a different time period of a glucose setpoint profile.

18. The one or more non-transitory processor-readable storage media of claim 17 , wherein the glucose setpoint profile is automatically calculated based on historical data associated with operation of the insulin infusion device.

19. The one or more non-transitory processor-readable storage media of claim 17 , wherein the glucose setpoint profile is obtained from a remote system or device.

20. The one or more non-transitory processor-readable storage media of claim 15 , wherein the clinically preferred target value is automatically determined based on historical data associated with operation of the insulin infusion device.

Assignments (2)
SECURITY INTEREST Recorded Jan 16, 2026
From: MEDTRONIC MINIMED, INC.; COMPANION MEDICAL, INC.
To: CITIBANK, N.A.
Reel/Frame 074394/0237 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 2, 2021
From: LINTEREUR, LOUIS J.; GROSMAN, BENYAMIN; ROY, ANIRBAN; PARIKH, NEHA J.; WU, DI
To: MEDTRONIC MINIMED, INC.
Reel/Frame 057058/0141 →